Nuveen Asset Management, LLC Akouos, Inc. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.46 - $5.2 $229,055 - $484,182	-93,112 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.16 - $9.08 $2,916 - $6,365	701 Added 0.76%	93,112 $426,000
Q4 2021 Feb 14, 2022	SELL	$7.65 - $11.38 $56,166 - $83,551	-7,342 Reduced 7.36%	92,411 $739,000
Q3 2021 Nov 12, 2021	SELL	$9.93 - $13.59 $252,192 - $345,145	-25,397 Reduced 20.29%	99,753 $1.25 Million
Q2 2021 Aug 16, 2021	BUY	$11.87 - $15.96 $434,038 - $583,593	36,566 Added 41.28%	125,150 $1.57 Million
Q1 2021 May 17, 2021	BUY	$13.87 - $21.04 $481,677 - $730,677	34,728 Added 64.48%	88,584 $1.23 Million
Q4 2020 Feb 16, 2021	SELL	$17.03 - $22.45 $1,873 - $2,469	-110 Reduced 0.2%	53,856 $1.07 Million
Q3 2020 Nov 16, 2020	BUY	$19.3 - $26.92 $1.04 Million - $1.45 Million	53,966 New	53,966 $1.23 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.